92 related articles for article (PubMed ID: 10756826)
1. [The prognostic factors for survival in advanced forms of non-small-cell lung cancer].
Miron L; Toma C; Ciornea LT
Rev Med Chir Soc Med Nat Iasi; 1998; 102(1-2):129-38. PubMed ID: 10756826
[TBL] [Abstract][Full Text] [Related]
2. [Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases].
Battikh MH; Ben Sayah MM; Joobeur S; Rouetbi N; Ben Salem K; Daami M; Maatallah A; Raham W; Farhat C; El Kamel A
Tunis Med; 2004 Sep; 82(9):843-8. PubMed ID: 15693478
[TBL] [Abstract][Full Text] [Related]
3. Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer.
Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
Acta Oncol; 2005; 44(1):75-9. PubMed ID: 15848909
[TBL] [Abstract][Full Text] [Related]
4. [Survival analysis and prognosis of lung cancer related factors].
Fan ZM; Shu ZG; Tan JP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):674-5. PubMed ID: 21882475
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival in advanced non-small cell lung cancer.
Laohavinij S; Maneechavakajorn J
J Med Assoc Thai; 2004 Sep; 87(9):1056-64. PubMed ID: 15516006
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
Huang EH; Liao Z; Cox JD; Guerrero TM; Chang JY; Jeter M; Borghero Y; Wei X; Fossella F; Herbst RS; Blumenschein GR; Moran C; Allen PK; Komaki R
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):779-85. PubMed ID: 17418967
[TBL] [Abstract][Full Text] [Related]
8. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
9. [Age-related prognostic factors and treatment results for advanced non-small cell lung cancer (NSCLC)].
Clement D; Miron L; Marinca M
Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):856-63. PubMed ID: 18389770
[TBL] [Abstract][Full Text] [Related]
10. Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy.
Cai XW; Xu LY; Wang L; Hayman JA; Chang AC; Pickens A; Cease KB; Orringer MB; Kong FM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1100-5. PubMed ID: 19540063
[TBL] [Abstract][Full Text] [Related]
11. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
[TBL] [Abstract][Full Text] [Related]
12. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of survival and prognostic factors of 2,000 broncho-pulmonary cancers registered during 10 years in a multidisciplinary oncology department].
Moro D; Nagy-Mignotte H; Bolla M; Colonna M; Brichon PY; Brambilla C; Schaerer R; Vrousos C
Bull Cancer; 1997 Feb; 84(2):155-61. PubMed ID: 9180838
[TBL] [Abstract][Full Text] [Related]
14. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
Maione P; Rossi A; Di Maio M; Gridelli C
Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
[TBL] [Abstract][Full Text] [Related]
15. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in patients with inoperable non-small cell lung cancer--an analysis of long-term survival patients.
Ohashi R; Takahashi K; Miura K; Ishiwata T; Sakuraba S; Fukuchi Y
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1595-602. PubMed ID: 17108725
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in resected T3 non-small cell lung carcinoma: perineural invasion as a new prognostic factor.
Demir A; Gunluoglu MZ; Kara HV; Buyukpinarbasili N; Dincer SI
Thorac Cardiovasc Surg; 2008 Mar; 56(2):93-8. PubMed ID: 18278684
[TBL] [Abstract][Full Text] [Related]
18. Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival?
Wang T; Nelson RA; Bogardus A; Grannis FW
Cancer; 2010 Mar; 116(6):1518-25. PubMed ID: 20108308
[TBL] [Abstract][Full Text] [Related]
19. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
Wakelee HA; Bernardo P; Johnson DH; Schiller JH
Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
[TBL] [Abstract][Full Text] [Related]
20. Effect of delays on prognosis in patients with non-small cell lung cancer.
Myrdal G; Lambe M; Hillerdal G; Lamberg K; Agustsson T; Ståhle E
Thorax; 2004 Jan; 59(1):45-9. PubMed ID: 14694247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
